Shao ZM - Search Results

1

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.

Xiao Y, Ma D, Zhao S, Suo C, Shi J, Xue MZ, Ruan M, Wang H, Zhao J, Li Q, Wang P, Shi L, Yang WT, Huang W, Hu X, Yu KD, Huang S, Bertucci F, Jiang YZ, Shao ZM; AME Breast Cancer Collaborative Group. Xiao Y, et al. Among authors: shao zm. Clin Cancer Res. 2019 Aug 15;25(16):5002-5014. doi: 10.1158/1078-0432.CCR-18-3524. Epub 2019 Mar 5. Clin Cancer Res. 2019. PMID: 30837276

2

p53 mutation in plasma DNA and its prognostic value in breast cancer patients.

Shao ZM, Wu J, Shen ZZ, Nguyen M. Shao ZM, et al. Clin Cancer Res. 2001 Aug;7(8):2222-7. Clin Cancer Res. 2001. Retraction in: Clin Cancer Res. 2002 Sep;8(9):3027. PMID: 11489795 Retracted.

3

The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.

Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM. Shen Z, et al. Among authors: shao zm. Clin Cancer Res. 2002 Jul;8(7):2085-90. Clin Cancer Res. 2002. PMID: 12114407

4

The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.

Song CG, Hu Z, Wu J, Luo JM, Shen ZZ, Huang W, Shao ZM. Song CG, et al. Among authors: shao zm. J Cancer Res Clin Oncol. 2006 Oct;132(10):617-26. doi: 10.1007/s00432-006-0105-9. Epub 2006 Jul 12. J Cancer Res Clin Oncol. 2006. PMID: 16835750

5

[CHEK2 c.1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China].

Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM. Song CG, et al. Among authors: shao zm. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Aug;23(4):443-5. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006. PMID: 16883537 Chinese.

6

Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.

Dong HM, Liu G, Hou YF, Wu J, Lu JS, Luo JM, Shen ZZ, Shao ZM. Dong HM, et al. Among authors: shao zm. J Cancer Res Clin Oncol. 2007 Feb;133(2):83-92. doi: 10.1007/s00432-006-0140-6. Epub 2006 Aug 24. J Cancer Res Clin Oncol. 2007. PMID: 16932944

7

Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.

Wang L, Shao ZM. Wang L, et al. Among authors: shao zm. Cancer Invest. 2006 Oct;24(6):581-7. doi: 10.1080/07357900600894799. Cancer Invest. 2006. PMID: 16982462

8

Clinical significance of aromatase protein expression in axillary node negative breast cancer.

Lu J, Li H, Cao D, Di G, Wu J, Sheng K, Han Q, Shen Z, Shao Z. Lu J, et al. J Cancer Res Clin Oncol. 2007 Jun;133(6):401-9. doi: 10.1007/s00432-006-0186-5. Epub 2007 Jan 12. J Cancer Res Clin Oncol. 2007. PMID: 17219197

9

Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.

Yu KD, Liu GY, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: shao zm. Breast. 2007 Jun;16(3):307-15. doi: 10.1016/j.breast.2006.12.011. Epub 2007 Feb 12. Breast. 2007. PMID: 17293115

10

A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.

Hu Z, Song CG, Lu JS, Luo JM, Shen ZZ, Huang W, Shao ZM. Hu Z, et al. Among authors: shao zm. J Cancer Res Clin Oncol. 2007 Dec;133(12):969-78. doi: 10.1007/s00432-007-0244-7. Epub 2007 Jun 12. J Cancer Res Clin Oncol. 2007. PMID: 17562079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

643 results

Search Page

Filters